Brenda L. Wong, MD

Director of the DMD Program at UMass Chan Medical School.

Articles by Brenda L. Wong, MD

Implications of Newborn Screening for Duchenne Muscular Dystrophy Care: Brenda L. Wong, MD; Michael Kelly, PhD

ByBrenda L. Wong, MD,Michael Kelly, PhD,Isabella Ciccone, MPH

January 28th 2026

A duo of experts from CureDuchenne discussed how the inclusion of Duchenne muscular dystrophy on the Recommended Uniform Screening Panel can enable earlier diagnosis and inform decision-making in a rapidly evolving therapeutic landscape. [WATCH TIME: 7 minutes]

Strengthening Duchenne Care Through Clinical Collaboration and Community Focus: Brenda L. Wong, MD

ByBrenda L. Wong, MD,Isabella Ciccone, MPH

June 15th 2025

The director of the DMD Program at UMass Chan Medical School shared her experience at the 2025 CureDuchenne FUTURES National Conference, held May 22-25, in San Antonio, Texas. [WATCH TIME: 5 minutes]

Brenda L. Wong, MD

Articles by Brenda L. Wong, MD

Implications of Newborn Screening for Duchenne Muscular Dystrophy Care: Brenda L. Wong, MD; Michael Kelly, PhD

Strengthening Duchenne Care Through Clinical Collaboration and Community Focus: Brenda L. Wong, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Anti-IL6R Therapy Effective in Reducing NMOSD and MOGAD Disease Activity

FDA Clears KORU FreedomEDGE System to Administer Rozanolixizumab-noli in gMG

Taysha Doses First Patient in Pivotal Trial for Rett Syndrome Gene Therapy TSHA-102, Aligns With FDA on BLA Plans

VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia

Phase 3 EMBARK Data Released, CTE Associated with Dementia Risk, Pilavapadin Heads to Phase 3 Pain Studies